Terms ending in 2031
Every in-force patent on RIKEN's record whose computed term ends in 2031, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 8,945,922 | Generating a mature NKT cell from a reprogrammed somatic cell with a T-cell antigen receptor alpha-chain region rearranged to uniform Va-Ja in a NKT-cell specific way. In force · High confidence | RIKEN | In force | High confidence | |
| US 9,557,341 | Risk Assessment for Cutaneous Adverse Drug Reactions from Antiretroviral Agent Mahidol University, Thailand Center of Excellence for Life Sciences (Okmd), Department of Medical Sciences, Ministry of Public Health and RIKEN In force · High confidence | Mahidol University, Thailand Center of Excellence for Life Sciences (Okmd), Department of Medical Sciences, Ministry of Public Health and RIKEN | In force | High confidence | |
| US 8,895,712 | Artificial Base Pair Capable of Forming Specific Base Pair In force · High confidence | Tagcyx Biotechnologies | In force | High confidence | |
| US 9,125,384 | Mouse Having Human Leukemic Stem Cell and Leukemic Non-Stem Cell Amplified Therein, and Method for Production Thereof In force · High confidence | The Jackson Laboratory | In force | High confidence | |
| US 10,695,362 | Stabilization Method of Functional Nucleic Acid In force · High confidence | Tagcyx Biotechnologies Inc. | In force | High confidence | |
| US 8,691,578 | Method for Generating Homoplasmic Cells from Heteroplasmic Cells In force · High confidence | National Center of Neurology and Psychiatry | In force | High confidence | |
| US 9,193,980 | Triterpene Oxidase Derived from Plant Belonging to Genus Glycyrrhiza, Gene Encoding the Same, and Method of Using the Same In force · High confidence | RIKEN | In force | High confidence | |
| US 8,956,606 | Malignant Tumor Cell Suppressor Protein, Malignant Tumor Cell Suppressor Gene, Maligant Tumor Cell Suppressive Viral Vector, and Kit Using the Same Andoh, Toshiwo In force · High confidence | Andoh, Toshiwo | In force | High confidence | |
| US 8,518,654 | Lung Cancer Diagnostic Polypeptide, Method for Detecting Lung Cancer, and Method for Evaluating Therapeutic Effect In force · High confidence | RIKEN and Shimadzu Corporation | In force | High confidence | |
| US 9,097,727 | Method for Diagnosing a Protein Misfolding Disease Using Nerve Cells Derived from Ips Cells In force · High confidence | Kyoto University | In force | High confidence | |
| 6 more term ends in 2031 · Pro | |||||
10 of 16 patents shown. Soonest term end first, then patent number.
Pro members see all 16.
7 of these are in force and held by RIKEN.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.